Previous Close | 172.57 |
Open | 173.74 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's Range | 170.41 - 174.28 |
52 Week Range | 151.03 - 201.92 |
Volume | |
Avg. Volume | 2,466,086 |
Market Cap | 78.153B |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | 33.67 |
EPS (TTM) | 5.07 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | 1.73 (1.01%) |
Ex-Dividend Date | Apr 18, 2024 |
1y Target Est | 225.85 |
Subscribe to Yahoo Finance Plus to view Fair Value for ZTS
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zoetis Inc (NYSE:ZTS), a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, saw a recent insider transaction by Director Willie Reed.
PARSIPPANY, N.J., March 05, 2024--Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 8:30 a.m. ET.